SCHEMBL1012265

SCHEMBL1012265

Nc1nc2ccccc2cc1C1C2CNCC21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR8 Q9NR97 8/20 0.42
ALDH1A1 P00352 5/20 0.42
KDM4E B2RXH2 4/20 0.42
GAA P10253 4/20 0.42
IKBKB O14920 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
KMT2A Q03164 3/20 0.40
MEN1 O00255 1/20 0.40
HPGD P15428 3/20 0.39
MAPT P10636 3/20 0.39
GLA P06280 2/20 0.39
ACHE P22303 1/20 0.39
HSD17B10 Q99714 1/20 0.39
ATM Q13315 1/20 0.39
HTR3A P46098 1/20 0.39
LMNA P02545 1/20 0.38
POLB P06746 1/20 0.38
PTBP1 P26599 1/20 0.38
RCE1 Q9Y256 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24092011 0.76 TLR8 (0.47) TLR8ALDH1A1KDM4EGAAIKBKB
SCHEMBL23405034 0.73 TLR8 (0.45) TLR8ALDH1A1KDM4EGAAIKBKB
SCHEMBL13679501 0.68 CHRNB4 (0.52) HTR3A
SCHEMBL29454362 0.67 TLR8 (0.57) TLR8ALDH1A1KDM4EGAAIKBKB
SCHEMBL359102 0.67 TLR8 (0.57) TLR8ALDH1A1KDM4EGAAIKBKB
SCHEMBL32689383 0.66 MEN1 (0.58) ALDH1A1KDM4EGAANPC1RAB9A
Hydrochloric Acid SCHEMBL27365120 0.65 TLR8 (0.55) TLR8ALDH1A1KDM4EGAAIKBKB
SCHEMBL31142917 0.65 SSTR4 (0.36) ALDH1A1KDM4ERAB9AKMT2AHPGD
SCHEMBL24969944 0.65 SSTR4 (0.36) ALDH1A1KDM4ERAB9AKMT2AHPGD
Hydrochloric Acid SCHEMBL30903344 0.64 SSTR4 (0.36) ALDH1A1KDM4ERAB9AKMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932246-B2 Histone deacetylase inhibitors CHROMA THERAPEUTICS LTD. (GB) 2011-04-26 US disclosed
EP-1881977-B1 HISTONE DEACETYLASE INHIBITORS CHROMA THERAPEUTICS LTD (GB) 2011-01-05 EP disclosed
US-20100152155-A1 Histone Deacetylase Inhibitors CHROMA THERAPEUTICS LTD. (GB) 2010-06-17 US disclosed
EP-1881977-A1 HISTONE DEACETYLASE INHIBITORS Chroma Therapeutics Limited (GB) 2008-01-30 EP disclosed
WO-2006123121-A1 HISTONE DEACETYLASE INHIBITORS CHROMA THERAPEUTICS LTD (GB) 2006-11-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100152155-A1 Histone Deacetylase Inhibitors HDAC1, HDAC2, HDAC11 TLR8 4383/4885ALDH1A1 741/4885KDM4E 281/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.